S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers

Fresenius Medical Care AG & Co. KGaA (FMS) Stock Forecast, Price & News

$21.54
-0.12 (-0.55%)
(As of 09/29/2023 ET)
Compare
Today's Range
$21.52
$21.82
50-Day Range
$21.31
$26.61
52-Week Range
$12.78
$27.72
Volume
448,965 shs
Average Volume
382,863 shs
Market Capitalization
$12.64 billion
P/E Ratio
20.51
Dividend Yield
1.95%
Price Target
$30.98

Fresenius Medical Care AG & Co. KGaA MarketRank™ Forecast

Analyst Rating
Reduce
1.90 Rating Score
Upside/​Downside
43.8% Upside
$30.98 Price Target
Short Interest
Healthy
0.18% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.74mentions of Fresenius Medical Care AG & Co. KGaA in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
23.26%
From $1.29 to $1.59 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.72 out of 5 stars

Medical Sector

91st out of 972 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

2nd out of 7 stocks


FMS stock logo

About Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock

Fresenius Medical Care AG & Co. KGaA provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

FMS Price History

FMS Stock News Headlines

[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
Here's Why You Should Retain Fresenius Medical (FMS) for Now
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
Fresenius Q2 EBIT Before Special Items Declines
See More Headlines
Receive FMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

FMS Company Calendar

Last Earnings
8/02/2023
Today
10/01/2023
Next Earnings (Estimated)
10/30/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Employees
1,235
Year Founded
1912

Price Target and Rating

Average Stock Price Forecast
$30.98
High Stock Price Forecast
$44.00
Low Stock Price Forecast
$11.70
Forecasted Upside/Downside
+43.8%
Consensus Rating
Reduce
Rating Score (0-4)
1.90
Research Coverage
10 Analysts

Profitability

Net Income
$709.50 million
Pretax Margin
5.74%

Debt

Sales & Book Value

Annual Sales
$20.44 billion
Cash Flow
$4.94 per share
Book Value
$27.74 per share

Miscellaneous

Free Float
N/A
Market Cap
$12.64 billion
Optionable
Optionable
Beta
1.06

Social Links

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Ms. Helen Giza (Age 55)
    CEO, Acting CFO & Chair of Mgmt Board of Fresenius Med. Care Mgmt AG
    Comp: $3.45M
  • Dr. Franklin W. Maddux F.A.C.P. (Age 66)
    Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG
    Comp: $2.59M
  • Mr. William J. Valle (Age 63)
    Management Board Member for Care Delivery of Fresenius Medical Care Management AG
    Comp: $4.22M
  • Dr. Katarzyna Mazur-Hofsab Ph.D. (Age 60)
    Management Board Member for Care Enablement of Fresenius Medical Care Management AG
    Comp: $2.51M
  • Mr. Roberto Fuste (Age 71)
    Exec. Advisor for Regional Strategy
  • Dr. Dominik Heger
    Exec. VP and Head of Investor Relations, Strategic Devel. & Communications
  • Mr. Borries Von Muller (Age 62)
    Sr. VP of Global HR Employee Communications
  • Mr. Joachim Weith
    Sr. VP of Corp. Communications & Gov.al Affairs
  • Mr. Oliver Maier
    Sr. VP Investor Relations
  • Dr. Gail-Suzanne Brown
    Sr. VP of R&D













FMS Stock - Frequently Asked Questions

Should I buy or sell Fresenius Medical Care AG & Co. KGaA stock right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. KGaA in the last twelve months. There are currently 2 sell ratings, 7 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "reduce" FMS shares.
View FMS analyst ratings
or view top-rated stocks.

What is Fresenius Medical Care AG & Co. KGaA's stock price forecast for 2023?

10 brokers have issued 1-year price targets for Fresenius Medical Care AG & Co. KGaA's stock. Their FMS share price forecasts range from $11.70 to $44.00. On average, they expect the company's stock price to reach $30.98 in the next year. This suggests a possible upside of 43.8% from the stock's current price.
View analysts price targets for FMS
or view top-rated stocks among Wall Street analysts.

How have FMS shares performed in 2023?

Fresenius Medical Care AG & Co. KGaA's stock was trading at $16.34 at the start of the year. Since then, FMS stock has increased by 31.8% and is now trading at $21.54.
View the best growth stocks for 2023 here
.

Are investors shorting Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 1,080,000 shares, an increase of 24.6% from the August 31st total of 867,000 shares. Based on an average daily volume of 411,900 shares, the days-to-cover ratio is presently 2.6 days.
View Fresenius Medical Care AG & Co. KGaA's Short Interest
.

When is Fresenius Medical Care AG & Co. KGaA's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, October 30th 2023.
View our FMS earnings forecast
.

How were Fresenius Medical Care AG & Co. KGaA's earnings last quarter?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) announced its earnings results on Wednesday, August, 2nd. The company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.24 by $0.08. The company had revenue of $5.25 billion for the quarter, compared to analyst estimates of $5.19 billion. Fresenius Medical Care AG & Co. KGaA had a net margin of 3.01% and a trailing twelve-month return on equity of 5.15%.

How often does Fresenius Medical Care AG & Co. KGaA pay dividends? What is the dividend yield for Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA announced an annual dividend on Wednesday, May 3rd. Shareholders of record on Thursday, May 18th will be given a dividend of $0.7086 per share on Thursday, June 1st. This represents a yield of 2.1%. The ex-dividend date of this dividend is Wednesday, May 17th.
Read our dividend analysis for FMS
.

What ETFs hold Fresenius Medical Care AG & Co. KGaA's stock?

ETFs with the largest weight of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) stock in their portfolio include Invesco International Dividend Achievers ETF (PID).Cultivar ETF (CVAR).

Is Fresenius Medical Care AG & Co. KGaA a good dividend stock?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) pays an annual dividend of $0.42 per share and currently has a dividend yield of 1.93%. The dividend payout ratio is 40.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, FMS will have a dividend payout ratio of 26.42% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for FMS.

What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. KGaA investors own include Energy Transfer (ET), Petra Diamonds (PDL), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), Chevron (CVX) and Ford Motor (F).

What is Fresenius Medical Care AG & Co. KGaA's stock symbol?

Fresenius Medical Care AG & Co. KGaA trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."

How do I buy shares of Fresenius Medical Care AG & Co. KGaA?

Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Fresenius Medical Care AG & Co. KGaA's stock price today?

One share of FMS stock can currently be purchased for approximately $21.54.

How much money does Fresenius Medical Care AG & Co. KGaA make?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) has a market capitalization of $12.64 billion and generates $20.44 billion in revenue each year. The company earns $709.50 million in net income (profit) each year or $1.05 on an earnings per share basis.

How many employees does Fresenius Medical Care AG & Co. KGaA have?

The company employs 1,235 workers across the globe.

Does Fresenius Medical Care AG & Co. KGaA have any subsidiaries?
The following companies are subsidiares of Fresenius Medical Care AG & Co. KGaA: NxStage Medical.
Read More
How can I contact Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA's mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The official website for the company is www.freseniusmedicalcare.com. The company can be reached via phone at (496) 172-6090, via email at ir@fmc-ag.com, or via fax at 49-6172-609-2301.

This page (NYSE:FMS) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -